| 1 |
32838518 | Multiaction Platinum(IV) Prodrug Containing Thymidylate Synthase Inhibitor and Metabolic Modifier against Triple-Negative Breast Cancer. | 2020 Sep 8 |
1 |
| 2 |
30944635 | 5-Fluorouracil-based adjuvant chemotherapy improves the clinical outcomes of patients with lymphovascular invasion of upper urinary tract cancer and low expression of dihydropyrimidine dehydrogenase. | 2019 May |
2 |
| 3 |
28835573 | Higher Tissue Levels of Thymidylate Synthase Determined by ELISA Are Associated with Poor Prognosis of Patients with Lung Cancer. | 2017 Aug |
1 |
| 4 |
25922722 | Variability in the anti-tumor effect of tegafur-uracil depending on histologic types of lung cancer. | 2015 Mar |
4 |
| 5 |
20647221 | Associations of various gene polymorphisms with toxicity in colorectal cancer patients receiving oral uracil and tegafur plus leucovorin: a prospective study. | 2011 Feb |
2 |
| 6 |
22870097 | Effect of leucovorin on the antitumor efficacy of the 5-FU prodrug, tegafur-uracil, in human colorectal cancer xenografts with various expression levels of thymidylate synthase. | 2010 Nov |
1 |
| 7 |
17143493 | Cyclophosphamide augments the anti-tumor efficacy of uracil and tegafur by inhibiting dihydropyrimidine dehydrogenase. | 2007 Jan |
3 |
| 8 |
17695427 | Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase expression in tumor tissue, regarding the efficacy of postoperatively administered UFT (tegafur+uracil) in patients with non-small cell lung cancer. | 2007 Jul-Aug |
1 |
| 9 |
15785747 | Clinical application of biological markers for treatments of resectable non-small-cell lung cancers. | 2005 Apr 11 |
1 |
| 10 |
15218314 | Low thymidylate synthase expression in the primary tumor predicts favorable clinical outcome in resected gastric cancer patients treated with adjuvant tegafur. | 2004 |
3 |
| 11 |
14636615 | Predictive value of immunohistochemical thymidylate synthase expression for histological response to Tegafur/Uracil (UFT) in oral squamous cell carcinoma. | 2003 Dec |
4 |
| 12 |
11201382 | [Theoretical construction of chemotherapeutic tactics for advanced or recurrent gastrointestinal carcinoma]. | 2001 Jan |
1 |
| 13 |
12450432 | Thymidylate synthase pharmacogenetics in colorectal cancer. | 2001 Nov |
4 |
| 14 |
10769701 | Do the expression of CD44, apoptosis and thymidylate synthase inhibition rate correlate with the efficacy of chemotherapy in colorectal cancer? | 2000 Jan-Feb |
1 |
| 15 |
9239165 | [Study of preoperative combination therapy with UFT + CDDP in patients with gastric and colorectal cancer--concomitant effects based on the thymidylate synthase inhibitory rat]. | 1997 Jul |
1 |
| 16 |
8765432 | Thymidylate synthase inhibition by an oral regimen consisting of tegafur-uracil (UFT) and low-dose leucovorin for patients with gastric cancer. | 1996 |
2 |
| 17 |
7487125 | [UFT/CDDP preoperative chemotherapy for progressive gastric cancer--histological antitumor effects and thymidylate synthase inhibition rate]. | 1995 Nov |
1 |
| 18 |
8464418 | [Changes of the number of FdUMP binding sites of thymidylate synthase and folate pools in human colorectal carcinomas following the administration of tegafur and uracil: preliminary report]. | 1993 Feb |
1 |
| 19 |
8468974 | Dependence of the thymidylate synthase inhibition rate on the interval after the last administration of tegafur in sigmoid colon cancer patients. | 1993 Feb |
1 |
| 20 |
1519926 | [Neo-adjuvant chemotherapy with tegafur suppository for rectal cancer--evaluation of the antitumor effects, tissue levels of 5-FU and inhibition of thymidylate synthase. Tochigi Colorectal Cancer Study Group]. | 1992 Sep |
1 |
| 21 |
1992915 | [Drug concentration in cancerous large bowel tissue and thymidylate synthase inhibition rate after administration of tegafur and UFT]. | 1991 Feb |
1 |
| 22 |
2495166 | 5-Fluorouracil and UFT-sensitive gastric carcinoma has a high level of thymidylate synthase. | 1989 May 1 |
6 |
| 23 |
6426401 | [Studies on the mechanism of antitumor activity of 5-FU and its derivatives--relationship between the inhibition of tumor growth and the inhibition of thymidylate synthetase in vivo]. | 1984 May |
1 |